| scholarly article | Q13442814 |
| P2093 | author name string | Albert H Kim | |
| Ayman H Fanous | |||
| Vernell Williamson | |||
| Vladimir I Vladimirov | |||
| Gowon O McMichael | |||
| Erin K Parker | |||
| P2860 | cites work | Principles of microRNA-target recognition | Q21146368 |
| New insights into the roles of microRNAs in drug addiction and neuroplasticity | Q21183972 | ||
| Genetics of bipolar disorder | Q81010615 | ||
| microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder | Q21184126 | ||
| Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study | Q22251379 | ||
| Schizophrenia is associated with an increase in cortical microRNA biogenesis | Q24595592 | ||
| Identifying gene regulatory networks in schizophrenia | Q24601410 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| MicroRNA dysregulation in psychiatric disease | Q24630375 | ||
| MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1 | Q24630616 | ||
| Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder | Q24655630 | ||
| miRecords: an integrated resource for microRNA-target interactions | Q24655642 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Prediction of mammalian microRNA targets | Q27860498 | ||
| Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies | Q28190066 | ||
| MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11) | Q28646071 | ||
| Identification of loci associated with schizophrenia by genome-wide association and follow-up | Q29417130 | ||
| The role of site accessibility in microRNA target recognition | Q29547436 | ||
| Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data | Q29616220 | ||
| Functional and evolutionary insights into human brain development through global transcriptome analysis | Q29617082 | ||
| Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation | Q29618303 | ||
| Brain expressed microRNAs implicated in schizophrenia etiology | Q33298597 | ||
| Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample | Q33554950 | ||
| Cross talk between microRNA and epigenetic regulation in adult neurogenesis | Q33788417 | ||
| The Psychosis Susceptibility Gene ZNF804A: Associations, Functions, and Phenotypes | Q34092630 | ||
| A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes | Q34128269 | ||
| ZNF804a regulates expression of the schizophrenia-associated genes PRSS16, COMT, PDE4B, and DRD2. | Q34182670 | ||
| Knockdown of the psychosis susceptibility gene ZNF804A alters expression of genes involved in cell adhesion. | Q34232304 | ||
| MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders | Q35216295 | ||
| Evidence for shared susceptibility in bipolar disorder and schizophrenia | Q35576972 | ||
| miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells | Q35818683 | ||
| Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder | Q37571848 | ||
| MicroRNAs in psychiatric and neurodevelopmental disorders | Q37730250 | ||
| A study of miRNAs targets prediction and experimental validation | Q37820385 | ||
| Allelic differences in nuclear protein binding at a genome-wide significant risk variant for schizophrenia in ZNF804A. | Q39584669 | ||
| Independent diagnoses of adoptees and relatives as defined by DSM-III in the provincial and national samples of the Danish Adoption Study of Schizophrenia | Q40756853 | ||
| The genetics of schizophrenia: a current, genetic-epidemiologic perspective | Q40821125 | ||
| Irish study on high-density schizophrenia families: field methods and power to detect linkage | Q45098096 | ||
| Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets | Q45263643 | ||
| The significance of genetic factors in the etiology of schizophrenia: results from the national study of adoptees in Denmark. | Q50548397 | ||
| Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. A family study using DSM-III criteria. | Q52082314 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 60-64 | |
| P577 | publication date | 2012-08-09 | |
| P1433 | published in | Schizophrenia Research | Q7431607 |
| P1476 | title | Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. | |
| P478 | volume | 141 |
| Q36994815 | A GWAS SNP for Schizophrenia Is Linked to the Internal MIR137 Promoter and Supports Differential Allele-Specific Expression |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q39026765 | A direct molecular link between the autism candidate gene RORa and the schizophrenia candidate MIR137. |
| Q34657883 | A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder |
| Q42507566 | Allelic imbalance associated with the schizophrenia risk SNP rs1344706 indicates a cis-acting variant in ZNF804A. |
| Q37120426 | Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex |
| Q34177537 | Association of a miRNA-137 polymorphism with schizophrenia in a Southern Chinese Han population. |
| Q28538182 | Association of impulsivity and polymorphic microRNA-641 target sites in the SNAP-25 gene |
| Q38293348 | Bioinformatic analyses and conceptual synthesis of evidence linking ZNF804A to risk for schizophrenia and bipolar disorder |
| Q38226316 | Carbonyl stress and schizophrenia |
| Q35369598 | Characterization of a REST-Regulated Internal Promoter in the Schizophrenia Genome-Wide Associated Gene MIR137. |
| Q38384194 | Determining the role of microRNAs in psychiatric disorders |
| Q43185270 | Differential regulation of schizophrenia-associated microRNA gene function by variable number tandem repeats (VNTR) polymorphism |
| Q36826582 | Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia |
| Q50419804 | Dysregulation of miRNA and its potential therapeutic application in schizophrenia. |
| Q36837420 | Expression quantitative trait loci (eQTLs) in microRNA genes are enriched for schizophrenia and bipolar disorder association signals |
| Q34603780 | Genetic underpinnings of white matter 'connectivity': heritability, risk, and heterogeneity in schizophrenia |
| Q34447816 | Heterogeneity and individuality: microRNAs in mental disorders |
| Q38751829 | Identification and Potential Regulatory Properties of Evolutionary Conserved Regions (ECRs) at the Schizophrenia-Associated MIR137 Locus. |
| Q31043232 | Integration of Multiple Genomic and Phenotype Data to Infer Novel miRNA-Disease Associations |
| Q38537765 | KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease |
| Q38989183 | MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets |
| Q39002120 | MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls |
| Q38952716 | MiR-137: an important player in neural development and neoplastic transformation. |
| Q41554837 | MiRNAs of peripheral blood as the biomarker of schizophrenia |
| Q35691087 | MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del. |
| Q37363559 | MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and Is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients |
| Q39185826 | MicroRNA-137 regulates a glucocorticoid receptor-dependent signalling network: implications for the etiology of schizophrenia |
| Q33676705 | MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant |
| Q34394249 | MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review |
| Q38843644 | MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments? |
| Q39414160 | MicroRNAs in neural development: from master regulators to fine-tuners |
| Q30442237 | Neurodevelopment in schizophrenia: the role of the wnt pathways |
| Q90114172 | Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development |
| Q34578760 | No effect of schizophrenia risk genes MIR137, TCF4, and ZNF804A on macroscopic brain structure |
| Q26851626 | Noncoding RNAs and neurobehavioral mechanisms in psychiatric disease |
| Q38103810 | Pitt-Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription. |
| Q90406392 | Polymorphism in schizophrenia risk gene MIR137 is associated with the posterior cingulate Cortex's activation and functional and structural connectivity in healthy controls |
| Q30454963 | Potential Impact of miR-137 and Its Targets in Schizophrenia |
| Q38260258 | Recent genetic findings in schizophrenia and their therapeutic relevance |
| Q35596962 | Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation |
| Q52148949 | The Multifarious Hippocampal Functions of MicroRNA-137. |
| Q26752281 | The SNP rs1625579 in miR-137 gene and risk of schizophrenia in Chinese population: A meta-analysis |
| Q48140110 | The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia |
| Q33923604 | The impact of MIR137 on dorsolateral prefrontal-hippocampal functional connectivity in healthy subjects |
| Q41002359 | The impact of genome wide supported microRNA-137 (MIR137) risk variants on frontal and striatal white matter integrity, neurocognitive functioning, and negative symptoms in schizophrenia. |
| Q91945137 | The role of polygenic risk score gene-set analysis in the context of the omnigenic model of schizophrenia |
| Q38450466 | The schizophrenia risk gene MIR137 acts as a hippocampal gene network node orchestrating the expression of genes relevant to nervous system development and function. |
| Q37706529 | Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells |
| Q38979078 | Transcriptional targets of the schizophrenia risk gene MIR137. |
| Q35079675 | Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder |
| Q37645440 | miR-137: a new player in schizophrenia |
| Q36463734 | miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome |
| Q60958314 | microRNAs Sculpt Neuronal Communication in a Tight Balance That Is Lost in Neurological Disease |
Search more.